Oppenheimer Keeps a Buy Rating on Integra Lifesciences

Ruben Hill
April 26, 2018

About 429,057 shares traded. IntelGenx Technologies Corp. (CVE:IGX) has 0.00% since April 24, 2017 and is. It has outperformed by 4.07% the S&P500. Cardinal Management invested 0.26% in Integra LifeSciences Holdings Corporation (NASDAQ:IART). IART's profit will be $38.69 million for 27.86 P/E if the $0.49 EPS becomes a reality. The business's revenue was up 38.1% compared to the same quarter last year. equities research analysts predict that Integra lifesciences will post 2.33 EPS for the current fiscal year. About 319,061 shares traded. Integra LifeSciences Holdings Corporation (NASDAQ:IART) has risen 29.35% since April 24, 2017 and is uptrending. It has outperformed by 17.80% the S&P500.

Advanta Home Equity Loan Trust 1993-3 (IART) investors sentiment decreased to 0.98 in 2017 Q4. It turned negative, as 20 investors sold Integra LifeSciences Holdings Corporation shares while 70 reduced holdings. 23 funds bought holdings and 65 increased holdings. Regions Fincl holds 0.01% in Integra LifeSciences Holdings Corporation (NASDAQ:IART) or 11,474 shares.

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)'s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as -20.7 percent. Susquehanna Intll Gru Ltd Liability Partnership invested in 0% or 43,332 shares. Atlanta Cap L L C invested 0.17% in Integra LifeSciences Holdings Corporation (NASDAQ:IART). 16,627 are held by Rafferty Asset Mgmt Limited Liability Com. Royal Bancorporation Of Canada has invested 0.02% of its capital in Integra LifeSciences Holdings Corporation (NASDAQ:IART). Alliancebernstein L P owns 93,116 shs or 0% of their U.S. capital. Diversified Trust Co now owns 13,317 shares of the life sciences company's stock valued at $637,000 after acquiring an additional 1,047 shares in the last quarter. California State Teachers Retirement holds 100,307 shares. 125,992 are held by Segall Bryant Hamill Lc. Also, VP Joseph Vinhais sold 6,800 shares of the firm's stock in a transaction dated Friday, March 9th. Arizona State Retirement Systems owns 106,839 shares or 0.05% of their USA portfolio. The life sciences company reported $0.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.49 by $0.09.

Integra LifeSciences Holdings Corporation (IART) is U.S. based company. Clearbridge Invs Lc has 0.06% invested in Integra LifeSciences Holdings Corporation (NASDAQ:IART). BidaskClub upgraded Integra lifesciences from a "sell" rating to a "hold" rating in a research report on Thursday, March 15th. Therefore 54% are positive. On Friday, October 27 the stock of Integra LifeSciences Holdings Corporation (NASDAQ:IART) has "Hold" rating given by J.P. Morgan. On Monday, October 30 the stock of Integra LifeSciences Holdings Corporation (NASDAQ:IART) earned "Market Perform" rating by Wells Fargo. The firm has "Buy" rating by Oppenheimer given on Wednesday, July 26. The firm earned "Overweight" rating on Wednesday, July 13 by JP Morgan. The rating was maintained by Raymond James with "Outperform" on Thursday, July 27. Jefferies Group LLC lifted their price target on shares of Integra LifeSciences Holdings Corporation from $52.00 to $58.00 and gave the stock a "buy" rating in a report on Wednesday, May 31st. RBC Capital Markets maintained it with "Sector Perform" rating and $46 target in Friday, January 13 report. The stock has "Hold" rating by RBC Capital Markets on Friday, September 1. Integra LifeSciences Holdings Corporation had a net margin of 6.66% and a return on equity of 16.67%. The company has market cap of $2.92 billion. It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments. It has a 10.97 P/E ratio. It offers neurosurgery and critical care products, including tissue ablation equipment, dural fix products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The stock has a consensus rating of Hold and a consensus target price of $55.82. Therefore 94% are positive. Integra lifesciences has a 12-month low of $41.51 and a 12-month high of $59.30. $58.86's average target is 2.47% above currents $57.44 stock price. QEP Resources had 68 analyst reports since August 7, 2015 according to SRatingsIntel. As per Tuesday, January 2, the company rating was downgraded by Bank of America. The stock of CoreLogic, Inc. As per Tuesday, March 29, the company rating was upgraded by Robert W. Baird. Barclays Capital maintained the stock with "Equalweight" rating in Thursday, June 2 report. As per Wednesday, November 18, the company rating was downgraded by TD Securities. The rating was maintained by Piper Jaffray on Thursday, October 12 with "Hold". The firm earned "Overweight" rating on Monday, August 3 by JP Morgan.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article